Nationwide recall issued for common hypertension drug due to dissolution defect
More than 11,000 bottles of chlorthalidone tablets (25 mg) used to treat high blood pressure have been recalled nationwide after a manufacturing issue caused dissolution specifications to fail. Inventia Healthcare Limited initiated the voluntary recall on June 5, with 100-count bottles (Lot RISA24001) and 1,000-count bottles (Lot RISB24002) distributed in the U.S. by Rising Pharma Holdings Inc. The FDA has not yet assigned a recall classification, and no public press release had been issued; patients should contact their pharmacist or healthcare provider if they believe they have a recalled bottle and should not stop taking prescribed medication without medical advice.